CD8A and neoplasm: We found that CLTCH129>Q-specific T cell receptors (TCRs) differed in their avidity for antigen but were nonetheless similarly able to undergo antigen-dependent expansion in vivo and provide CD8+ T cell- and CD40L-dependent protection from tumor challenge.